Conagra Brands Q4 fiscal 2026 net sales hits $2.9 billion
Conagra Brands (NYSE:CAG) reported Q4 fiscal 2026 net sales of $2.9 billion, a diluted loss of $3.37 per share and an annualized dividend cut to $0.70.
Conagra Brands (NYSE:CAG) reported Q4 fiscal 2026 net sales of $2.9 billion, a diluted loss of $3.37 per share and an annualized dividend cut to $0.70.
Morgan Stanley (NYSE:MS) reported record Q2 2026 net revenue of $21.3 billion and diluted EPS of $3.46 as its major business divisions expanded.
Bruker (NASDAQ:BRKR) acquired DISQVER, an mNGS platform that can analyze blood-derived cell-free DNA for more than 11,000 microbes within 24 hours.
Axsome Therapeutics (NASDAQ:AXSM) announced the FDA accepted its New Drug Application for narcolepsy treatment AXS-12, setting a 2027 target date.
Veradermics (NYSE:MANE) reported that its VDPHL01 treatment produced an average increase of up to 23.3 hairs per square centimeter in female patients over six months.
US President Donald Trump has reversed his decision to impose a 20% toll on ships transiting the Strait of Hormuz, opting instead to pursue investment commitments from Gulf States into the United States economy.
Highway Holdings (NASDAQ:HIHO) reported fiscal 2026 revenue of $4.8 million and a shareholder-attributable net loss of $1.5 million, or $0.33 per share.
Pediatrix Medical Group (NYSE:MD) said its second-quarter payor mix remained stable and reaffirmed its $280–$300 million 2026 Adjusted EBITDA outlook.
BNY (NYSE:BNY) reported second-quarter revenue of $5.7 billion alongside an adjusted earnings per share of $2.45.
VCI Global (NASDAQ:VCIG) reported fiscal 2025 revenue of $26.1 million, down 6.2%, and a net loss attributable to shareholders of $30.3 million.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy